IFNG and neoplasm: Recent studies have uncovered that Sb9 can be modulated by MUC1-C-IFNγ oncogenic signaling via the interferon regulator factor 1 (IRF1) transcription factor and by type 1 interferon in murine tumor cells (50–52).